Olive Leaf Extracts in the Control of Cardiovascular Risk
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This study will be carried out in 2 emergency departments (at the exit of the emergency room)
and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology
consultation, Jemmal hospital).
Patients over 18 years of age with:
1. Arterial hypertension (hypertension).
2. Or diabetes.
3. Or one or more other cardiovascular risk factors (AHA, ESC) or risk of cardiovascular
disease> 20% according to the Framingham scale (apart from hypertension and diabetes
were included.